 |
Pharmaceuticals Management
"The founders of Medicare a half-century ago established the principle of equity of access to hospitals and doctors' services for all Canadians. First Ministers agree that no Canadians should suffer undue financial hardship in accessing needed drug therapies. Affordable access to drugs is fundamental to equitable health outcomes for all our citizens."-10-Year Plan to Strengthen Health Care
 |
Progress Report 2013: Health care renewal in Canada | |
| May 2013 | ||
In Progress Report 2013: Health care renewal in Canada, the Health Council reports on the progress made by jurisdictions in five priority areas of the health accords:
|
||
|
||
 |
Progress Report 2011: Health care renewal in Canada | |
| May 2011 | ||
| This report on Canada's health care performance is a pan-Canadian look at five key commitments under the 2003 First Ministers' Accord on Health Care Renewal and the 2004 10-Year Plan to Strengthen Health Care, and it highlights progress to date on wait times, pharmaceuticals management, electronic health records, teletriage, and health care innovation. Read more | ||
|
|
||
 |
Keeping an Eye on Prescription Drugs: Keeping Canadians Safe | |
| November 2010 | ||
| Canadians are not adequately informed of the safety concerns around pharmaceuticals. To ensure drugs are used appropriately, with minimal harm to the patient, Canada needs to improve the way we monitor drugs before and after they enter the market. Find out how we can make drugs safer for Canadians. Read more | ||
|
|
||
 |
Decisions, Decisions: Family Doctors as Gatekeepers to Prescription Drugs and Diagnostic Imaging in Canada | |
| September 2010 | ||
| This report examines the increasingly complex role of family physicians and the effects of their decisions on the use of Canada's health care services. Read more | ||
|
|
||
 |
Generic Drug Pricing and Access in Canada: What are the Implications? | |
| June 2010 | ||
| This independent paper is designed to move the discussion of possible reforms forward on an important part of the drug file – the pricing and distribution of generic drugs - and to bring transparency to this crucial area of public health policy. Read more | ||
|
|
||
 |
The National Pharmaceuticals Strategy: A Prescription Unfilled | |
| January 2009 | ||
| In this report, we examine the problems that the 2004 National Pharmaceuticals Strategy was intended to address and its progress almost five years later. In a National Pharmaceuticals Strategy (NPS) launched in 2004, governments committed to make catastrophic drug coverage a priority. But Canadians still don’t have this coverage or other important reforms that were promised. Read more | ||
|
|
||
 |
Rekindling Reform: Health Care Renewal in Canada, 2003 – 2008 | |
| January 2008 | ||
| This report looks back at five years of activity intended to strengthen the capacity of the public health care system to deliver timely, high-quality care. The 2003 First Ministers’ Accord on Health Care Renewal has been a catalyst for positive change in some areas, less so in others, and the Health Council urges governments to rekindle their commitment to health care renewal. Read more | ||
|
|
||
 |
Safe and Sound: Optimizing Prescribing Behaviours – Summary of Main Themes and Insights | |
| October 2007 | ||
| This Health Council report is a collection of information and advice gathered at a policy symposium we held in Montreal on June 12-13, 2007 to assist in the continued development of Canada’s National Pharmaceuticals Strategy. Read more | ||
|
|
||
 |
Optimal Prescribing and Medication Use in Canada: Challenges and Opportunities | |
| May 2007 | ||
| This background paper summarizes the evidence from research on the effectiveness of various approaches to improving prescribing practices. It also highlights initiatives in Canada and abroad that are helping to make prescribing safer, more appropriate, and more effective. Read more | ||
|
|
||
 |
Health Care Renewal in Canada: Measuring Up? | |
| February 2007 | ||
| In this report, we set out three pathways to help steer us towards quality: quicker access to needed care, better quality services, and improved population health that factors in the need for support inside and outside the health care system. Read more | ||
|
|
||
 |
Canadian Perceptions of the Health Care System | |
| February 2007 | ||
| This report presents a synthesis of four years of public opinion polling data (2002 – 2006) on the Canadian health care system. These data are used to understand how Canadian perceptions have changed since the Romanow Commission (2002), including whether Canadians see the system as improving or deteriorating, and how they view governments’ performance on health care issues. Read more | ||
|
|
||
 |
Health Care Renewal in Canada: Clearing the Road to Quality | |
| February 2006 | ||
| In this report, we set out three pathways to help steer us towards quality: quicker access to needed care, better quality services, and improved population health that factors in the need for support inside and outside the health care system. Read more | ||
|
|
||
 |
Direct-to-Consumer Advertising of Prescription Drugs in Canada: What are the Public Health Implications? | |
| January 2006 | ||
| In this paper, written by University of British Columbia researcher Barbara Mintzes, we urge the government to curtail direct-to-consumer advertising of prescription drugs, in the interest of patient safety and public health. Read more | ||
|
|
||
 |
Health Care Renewal in Canada: Accelerating Change 2005 | |
| January 2005 | ||
| In this report, we set out three pathways to help steer us towards quality: quicker access to needed care, better quality services, and improved population health that factors in the need for support inside and outside the health care system. Read more | ||
|
|
||
 |
Pharmaceuticals In Canada | |
| January 2005 | ||
| A background paper to accompany Health Care Renewal in Canada: Accelerating Change (2005) Read more | ||
|
|
||
From Our Blogs (16)
Still overpaying for generic drugs
Still overpaying for generic...
Still overpaying for generic...
Related Articles (3)
Presentations (2)
Drug Safety and Effectiveness in Canada: Issues, Challenges and New Approaches
Presented at the 2011 CADTH Symposium by John G. Abbott, CEO, Health Council of Canada, with Joel Lexchin (York University), Mary Wiktorowicz (York University), Shilpi Majumder (Health Council of Canada)
Presented at the 2011 CADTH Symposium by John G. Abbott, CEO, Health Council of Canada, with Joel Lexchin (York University), Mary Wiktorowicz (York University), Shilpi Majumder (Health Council of Canada)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
